Continue with FacebookLooking to list your PhD opportunities? Log in here.
lung cancer PhD Projects, Programmes & Scholarships
We have 21 lung cancer PhD Projects, Programmes & Scholarships
PhD saved successfully
The role of extracellular vesicles in lung epithelial cell communication in health and disease
It is estimated that more than 1 bn people suffer from acute and chronic lung problems resulting in millions of deaths every year. Read more
Drugging the undruggable: Therapeutically targeting key drivers of pro- and anti-oncogenic signaling in brain cancer, lung cancer and leukemia
This is a unique opportunity for PhD study in the world-leading Cancer Research UK Cambridge Institute (CRUK CI), to start a research career in an environment committed to training outstanding cancer research scientists of the future. Read more
The role of extracellular vesicles in pulmonary epithelium
More than 1bn people suffer from acute and chronic lung problems resulting in millions of deaths every year. The respiratory disorders with the most significant impact on public health are asthma, COPD, lung cancer and lung infections1. Read more
Repurposing and enriching cardiovascular risk prediction model to identify people at risk of cancer – UCL (part of Health Data Research UK’s Big Data for Complex Disease Driver Programme)
Risk-stratified management of cardiovascular disease (CVD), where people without established disease receive preventative interventions and monitoring based on their 10-years predicted risk, has been highly successful to ensure healthcare resources are allocated to those most likely to benefit. Read more
Investigation of Cancer-Associated Fibroblast Self-directed Matrices to Inform Therapeutic Approaches to Refractory Cancers
Fixed term contract for 3 years, commencing January 2024. Bursary of £ 18,622 per annum and a full fee-waiver for UK tuition fees. Read more
Live cell imaging of epithelial cancer cell proliferation for therapy
The School of Molecular & Cellular Biology invites applications from prospective postgraduate researchers who wish to commence study for a PhD in the academic year 2023/24. Read more
Multi-omics data analysis for critical disease prediction
Personalised treatment is a new and strategic approach to separates patients into different groups based on their personal response or risk of disease so that treatments can be tailored to the individual patient. Read more
Towards meeting UN Sustainable Development Goals: Catalytic removal of environmental pollutants
Golovko group is looking for a strong candidate suitable to take up a UC Taumata Whanaketanga Whainga | Sustainable Development Goals PhD Scholarship and capable of making a difference in the area of catalytic removal of environmental pollutants. Read more
How can we reduce child malnutrition and obesity in the face of food insecurity and poverty?
Children in the UK face considerable challenges to growing up healthy and happy. Read more
Developing a pre-clinical human pancreatic cancer model to test novel immunotherapies.
Background. Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in humans. There is a high unmet medical need to develop new therapies for the treatment of this disease. Read more
Molecular characterization of galectin-ligand interactions in cancer and beyond
Galectins are multifunctional carbohydrate-binding proteins that are expressed by many types of human cells such as epithelial and immune cells. Read more
Deciphering key steps in the metastatic process of breast cancer by focusing on the role of MAFF
Breast cancer is the most common cancer in women, which has a high mortality rate in the UK. Tumour metastasis from breast cancer is associated with a poor prognosis due to its aggressiveness and limited treatment options. Read more
Personalising cancer treatment with modelling tumour evolution based on genomics biomarkers and PK/PD
Tumour heterogeneity is a major problem limiting the efficacy of targeted oncological therapies. Most advanced tumours eventually become resistant to the treatments, ultimately making the patient succumb to metastatic disease. Read more
Real world evidence in the study of different subtypes of breast, lung, and prostate cancers: phenotyping, synthetic arm trials, and target trial emulation (NDORMS 2024/9)
Precision medicine in oncology is changing the prognosis of numerous cancers. However, the identification of very specific and rare cancer subtypes is leading to challenges in the recruitment of enough subjects for randomised controlled trials. Read more
Glycan sensing technology for early and accurate cancer diagnosis
The Mendes group (https://www.birmingham.ac.uk/research/healthcare-technologies/research/nanoengineering-surface-chemistry/index.aspx) in the School of Chemical Engineering, University of Birmingham welcomes applications from prospective PhD students to conduct work in the area of glycan sensing technology for cancer diagnosis. Read more
- 1
- 2
